V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003151 | 320001887 | 1.74 | 64.8 | Neo-adjuvant (N) | null | 2014-05-16 | CARBOPLATIN + RT | null | null | 320018677 | CISPLATIN + GEMCITABINE |
| 320003152 | 320001888 | 1.8 | 83 | Adjuvant (A) | 2014-09-09 | 2014-09-14 | CARBOPLATIN + FLUOROURACIL | N | N | 320018692 | GEMCITABINE |
| 320003153 | 320001889 | 1.61 | 96 | Neo-adjuvant (N) | 2015-10-19 | 2015-10-26 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 320018693 | CETUXIMAB + RT |
| 320003154 | 320001889 | 1.69 | 60 | Neo-adjuvant (N) | 2013-11-23 | 2013-11-26 | Capecitabine + Oxaliplatin 21day | N | N | 320018693 | CETUXIMAB + RT |
| 320003155 | 320001890 | 1.82 | 84 | Palliative (P) | 2015-01-29 | 2015-02-02 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 320018722 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320003156 | 320001890 | 1.68 | 44.2 | Palliative (P) | 2014-06-20 | 2014-07-03 | CISPLATIN + ETOPOSIDE | null | N | 320018722 | CETUXIMAB + CISPLATIN + FU |
| 320003157 | 320001890 | 1.55 | null | Palliative (P) | 2017-01-19 | 2017-01-19 | ICON8 TRIAL | Y | N | 320018722 | CARBOPLATIN + ETOPOSIDE |
| 320003158 | 320001891 | 1.76 | 80 | Palliative (P) | 2017-02-13 | 2017-02-13 | CAPECITABINE + OXALIPLATIN | N | null | 320018760 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320003159 | 320001892 | 1.58 | 64 | Palliative (P) | 2016-09-06 | 2016-09-20 | CARBOPLATIN + ETOPOSIDE | N | N | 320018761 | CISPLATIN + GEMCITABINE |
| 320003160 | 320001892 | 1.56 | 61.3 | Curative (C) | 2017-10-30 | 2017-11-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 320018761 | BCG |
| 320003161 | 320001892 | 1.55 | 59 | Palliative (P) | 2017-06-03 | 2017-06-15 | Cisplatin+Gemcitabine (gallbladder) | N | N | 320018761 | CAPECITABINE + CARBOPLATIN |
| 320003162 | 320001893 | 0 | 104 | Palliative (P) | 2015-09-05 | 2015-09-12 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 320018777 | DACARBAZINE |
| 320003163 | 320001893 | 1.65 | 54 | Palliative (P) | 2017-12-06 | 2017-12-06 | Carboplatin + Etoposide iv&po | N | N | 320018777 | EOX |
| 320003164 | 320001894 | null | null | Adjuvant (A) | 2017-01-09 | 2017-01-16 | Cisplatin + Docetaxel +Fluorouracil | null | null | 320018801 | CISPLATIN + GEMCITABINE |
| 320003165 | 320001894 | 1.7 | 81.6 | Palliative (P) | 2017-12-24 | 2017-12-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 320018801 | HCX |
| 320003166 | 320001895 | 1.5 | 76.9 | Palliative (P) | 2016-02-18 | 2016-02-18 | Bevacizumab + Paclitaxel | 2 | N | 320018818 | CISPLATIN + ETOPOSIDE |
| 320003167 | 320001895 | null | 106.2 | Palliative (P) | 2013-10-18 | 2013-10-19 | PEMBROLIZUMAB | N | N | 320018818 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003168 | 320001896 | 1.71 | 66.75 | Palliative (P) | 2016-05-12 | 2016-05-12 | Dacarbazine | N | N | 320018821 | CAPECITABINE + CISPLATIN |
| 320003169 | 320001897 | 1.56 | null | Palliative (P) | 2016-08-25 | 2016-09-09 | CARBOPLATIN + ETOPOSIDE | N | N | 320018831 | CAPECITABINE |
| 320003173 | 320001899 | 1.64 | 76.1 | null | 2013-06-23 | 2013-06-27 | CETUXIMAB + RT | 2 | null | 320018845 | CETUXIMAB + CISPLATIN + FU |
| 320003174 | 320001900 | 0.02 | 70.5 | Palliative (P) | 2015-04-18 | 2015-04-29 | Enzalutamide | N | N | 320018849 | ECF |
| 320003175 | 320001900 | null | 50.3 | Palliative (P) | 2015-07-06 | 2015-07-09 | EVEROLIMUS | N | N | 320018849 | BEVACIZUMAB |
| 320003176 | 320001900 | 1.71 | 85.4 | Not known (9) | 2016-03-06 | 2016-03-22 | Cetuximab + Radiotherapy Maint | Y | N | 320018849 | CTD |
| 320003177 | 320001901 | 1.7 | 68.3 | Curative (C) | 2015-10-04 | 2015-10-31 | CETUXIMAB + RT | N | Y | 320018869 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003178 | 320001902 | 1.57 | 80.4 | Palliative (P) | 2012-12-07 | 2012-12-07 | Carboplatin + Liposomal Doxorubicin | N | N | 320018878 | POUT TRIAL |
| 320003179 | 320001903 | 1.57 | 75.8 | null | 2014-01-02 | 2014-01-02 | Paclitaxel 80mg/m2 day 1 8 15 | 1 | N | 320018881 | IPILIMUMAB |
| 320003180 | 320001904 | 1.76 | null | Curative (C) | 2015-05-13 | 2015-06-02 | CARBOPLATIN + RT | null | N | 320018883 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003181 | 320001904 | 1.71 | 73.3 | Palliative (P) | 2018-04-12 | 2018-04-26 | Carboplatin + Vinorelbine Oral | N | N | 320018883 | CARBOPLATIN + ETOPOSIDE |
| 320003182 | 320001905 | 1.7 | 75.5 | Palliative (P) | 2013-03-25 | 2013-04-02 | Pazopanib | Y | N | 320018895 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003183 | 320001906 | 1.51 | 55.2 | null | 2013-06-25 | 2013-07-02 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320018896 | CETUXIMAB |
| 320003184 | 320001907 | null | null | Curative (C) | 2014-02-04 | 2014-03-02 | Capecitabine + Cisplatin | 02 | Y | 320018906 | TRASTUZUMAB |
| 320003185 | 320001908 | 1.71 | null | Palliative (P) | 2016-03-17 | 2016-03-30 | ICON8 TRIAL | 02 | N | 320018908 | CARBOPLATIN + LIPOSOMAL DOX |
| 320003186 | 320001909 | 1.66 | 83 | Palliative (P) | 2014-03-13 | 2014-03-13 | ICON8 TRIAL | 99 | N | 320018909 | BLEOMYCIN |
| 320003187 | 320001909 | null | 71.45 | Adjuvant (A) | 2016-02-20 | 2016-03-19 | ICON8B TRIAL | 2 | Y | 320018909 | ICON8B TRIAL |
| 320003188 | 320001910 | 1.75 | 71 | null | 2013-11-22 | 2013-12-01 | CETUXIMAB + RT | N | N | 320018918 | TRIAL |
| 320003189 | 320001911 | null | 46 | Adjuvant (A) | 2014-07-06 | 2014-08-03 | Carboplatin + Etoposide iv&po | N | N | 320018940 | CISPLATIN + GEMCITABINE |
| 320003190 | 320001912 | 1.6 | 55.3 | Palliative (P) | 2014-01-21 | 2014-01-30 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 320018942 | PEMBROLIZUMAB |
| 320003191 | 320001913 | 1.66 | 45.7 | Palliative (P) | 2014-10-07 | 2014-10-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320018943 | CISPLATIN + GEMCITABINE |
| 320003192 | 320001913 | 1.61 | 73 | Palliative (P) | 2015-07-29 | 2015-08-06 | POUT TRIAL | 02 | N | 320018943 | CAPECITABINE + CISPLATIN |
| 320003193 | 320001913 | 1.62 | 64.5 | Not known (9) | 2017-05-25 | 2017-06-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 320018943 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003194 | 320001914 | 1.63 | 67.7 | Palliative (P) | 2018-01-10 | 2018-01-10 | CETUXIMAB + RT | 01 | N | 320018963 | IRINOTECAN + MDG |
| 320003195 | 320001915 | 1.8 | null | Neo-adjuvant (N) | null | 2014-10-06 | Cisplatin + Docetaxel +Fluorouracil | null | null | 320018965 | CETUXIMAB |
| 320003196 | 320001916 | 1.74 | 66.1 | Neo-adjuvant (N) | 2015-02-02 | 2015-04-13 | CETUXIMAB | null | null | 320018973 | ECX |
| 320003197 | 320001917 | 1.78 | 85.2 | Curative (C) | 2016-12-26 | 2017-01-09 | PEMBROLIZUMAB | N | Y | 320018974 | POUT TRIAL |
| 320003198 | 320001918 | 1.76 | 83.5 | Palliative (P) | 2016-04-20 | 2016-04-26 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 320018987 | GEMCITABINE |
| 320003199 | 320001918 | 1.64 | null | Neo-adjuvant (N) | 2014-04-27 | 2014-04-27 | Trial Unspecified | 02 | N | 320018987 | PEMBROLIZUMAB |
| 320003200 | 320001918 | 1.72 | 92.85 | Palliative (P) | 2015-05-21 | 2015-06-13 | CETUXIMAB + RT | N | null | 320018987 | CARBO + FLUOROURACIL |
| 320003201 | 320001919 | 1.31 | 90 | Palliative (P) | 2015-02-10 | 2015-03-03 | Cisplatin + Pemetrexed | 02 | Y | 320019003 | CAPECITABINE + CISPLATIN |
| 320003202 | 320001920 | 1.66 | 146 | Adjuvant (A) | 2017-05-05 | 2017-05-31 | Trial Unspecified | N | N | 320019010 | CISPLATIN + GEMCITABINE |
| 320003203 | 320001921 | 1.5 | 44.2 | Curative (C) | 2016-01-20 | 2016-01-21 | Cisplatin + Docetaxel +Fluorouracil | null | null | 320019024 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |